Journal Title
Biomedicines

BIOMEDICINES

ISSN / eISSN
2227-9059 / 2227-9059
Aims and Scope
Biomedicines (ISSN 2227-9059; CODEN: BIOMID) is an international, scientific, open access journal on biomedicines published quarterly online by MDPI.
Subject Area

BIOCHEMISTRY & MOLECULAR BIOLOGY

MEDICINE, RESEARCH & EXPERIMENTAL

PHARMACOLOGY & PHARMACY

CiteScore
3.70 View Trend
CiteScore Ranking
Category Quartile Rank
Medicine - Medicine (miscellaneous) Q2 #132/309
Medicine - General Biochemistry, Genetics and Molecular Biology Q2 #93/212
Web of Science Core Collection
Science Citation Index Expanded (SCIE) Social Sciences Citation Index (SSCI)
Indexed -
Category (Journal Citation Reports 2023) Quartile
BIOCHEMISTRY & MOLECULAR BIOLOGY - SCIE Q2
MEDICINE, RESEARCH & EXPERIMENTAL - SCIE Q2
PHARMACOLOGY & PHARMACY - SCIE Q1
Country/Area of Publication
SWITZERLAND
Publisher
Multidisciplinary Digital Publishing Institute (MDPI)
Annual Article Volume
3239
Open Access
YES
Contact
ST ALBAN-ANLAGE 66, BASEL, SWITZERLAND, CH-4052
Verified Reviews
Note: Verified reviews are sourced from across review platforms and social media globally.
It's not that I'm saying anything, I work in oncology. I submitted my paper to this journal unexpectedly, and it got published. I didn't intentionally aim for this journal, but the review process was very fast. There were two reviewers and one research editor, and they provided a lot of comments. The key point is that their feedback was very professional. I even suspected that my field might have ended up in the hands of these three individuals. One reviewer seemed like they were rejecting the paper, while the other two suggested major revisions. The editor ultimately decided on major revisions and requested additional experiments. After 20 days, I resubmitted the revised paper, and it underwent another round of major revisions, although the changes were not extensive. I don't think it can be considered as a major revision. I resubmitted it within 10 days, and I will receive the results in the next couple of days. Overall, I feel that this journal is quite professional. Once you see the reviewers' comments, you will understand. They pointed out everything that you might be afraid of being asked, which made me quite nervous. Although the publication fee is expensive, I still hope for acceptance. After all, the revisions were quite difficult. I will come back with good news if there is any, and if there is no news, it means bad news.
2021-03-20
When I submitted my first article, it was rejected. After making revisions, I submitted it again and it was rejected once more. I was not satisfied and added some experiments before submitting it again. Finally, it was accepted. Now, the impact factor of this journal has exceeded 6. I feel that it is becoming increasingly difficult to submit articles. I estimate that it may drop in the ranking next year, but I am optimistic about the potential increase in the impact factor.
2021-08-21

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started